Literature DB >> 31577933

NAD+ in Brain Aging and Neurodegenerative Disorders.

Sofie Lautrup1, David A Sinclair2, Mark P Mattson3, Evandro F Fang4.   

Abstract

NAD+ is a pivotal metabolite involved in cellular bioenergetics, genomic stability, mitochondrial homeostasis, adaptive stress responses, and cell survival. Multiple NAD+-dependent enzymes are involved in synaptic plasticity and neuronal stress resistance. Here, we review emerging findings that reveal key roles for NAD+ and related metabolites in the adaptation of neurons to a wide range of physiological stressors and in counteracting processes in neurodegenerative diseases, such as those occurring in Alzheimer's, Parkinson's, and Huntington diseases, and amyotrophic lateral sclerosis. Advances in understanding the molecular and cellular mechanisms of NAD+-based neuronal resilience will lead to novel approaches for facilitating healthy brain aging and for the treatment of a range of neurological disorders.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; NAD+; Parkinson’s disease; brain aging; mitochondria; mitophagy; neurodegeneration; neuronal plasticity; sirtuins

Year:  2019        PMID: 31577933      PMCID: PMC6787556          DOI: 10.1016/j.cmet.2019.09.001

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  225 in total

Review 1.  PARP inhibition: PARP1 and beyond.

Authors:  Michèle Rouleau; Anand Patel; Michael J Hendzel; Scott H Kaufmann; Guy G Poirier
Journal:  Nat Rev Cancer       Date:  2010-03-04       Impact factor: 60.716

2.  The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD+ Cleavage Activity that Promotes Pathological Axonal Degeneration.

Authors:  Kow Essuman; Daniel W Summers; Yo Sasaki; Xianrong Mao; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  Neuron       Date:  2017-03-22       Impact factor: 17.173

3.  Social memory, amnesia, and autism: brain oxytocin secretion is regulated by NAD+ metabolites and single nucleotide polymorphisms of CD38.

Authors:  Haruhiro Higashida; Shigeru Yokoyama; Jian-Jun Huang; Li Liu; Wen-Jie Ma; Shirin Akther; Chiharu Higashida; Mitsuru Kikuchi; Yoshio Minabe; Toshio Munesue
Journal:  Neurochem Int       Date:  2012-02-13       Impact factor: 3.921

4.  CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism.

Authors:  Juliana Camacho-Pereira; Mariana G Tarragó; Claudia C S Chini; Veronica Nin; Carlos Escande; Gina M Warner; Amrutesh S Puranik; Renee A Schoon; Joel M Reid; Antonio Galina; Eduardo N Chini
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

Review 5.  Rate control of the tricarboxylic acid cycle.

Authors:  H A Krebs
Journal:  Adv Enzyme Regul       Date:  1970

6.  NAD+ supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency.

Authors:  Yujun Hou; Sofie Lautrup; Stephanie Cordonnier; Yue Wang; Deborah L Croteau; Eduardo Zavala; Yongqing Zhang; Kanako Moritoh; Jennifer F O'Connell; Beverly A Baptiste; Tinna V Stevnsner; Mark P Mattson; Vilhelm A Bohr
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-05       Impact factor: 11.205

7.  Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice.

Authors:  Clare H Latta; Tiffany L Sudduth; Erica M Weekman; Holly M Brothers; Erin L Abner; Gabriel J Popa; Michael D Mendenhall; Floracita Gonzalez-Oregon; Kaitlyn Braun; Donna M Wilcock
Journal:  J Neuroinflammation       Date:  2015-03-04       Impact factor: 8.322

8.  Autophagy maintains the metabolism and function of young and old stem cells.

Authors:  Theodore T Ho; Matthew R Warr; Emmalee R Adelman; Olivia M Lansinger; Johanna Flach; Evgenia V Verovskaya; Maria E Figueroa; Emmanuelle Passegué
Journal:  Nature       Date:  2017-03-01       Impact factor: 49.962

9.  Decreased NAD+ in dopaminergic neurons.

Authors:  Samantha L Sison; Allison D Ebert
Journal:  Aging (Albany NY)       Date:  2018-04-28       Impact factor: 5.682

Review 10.  Complement in the pathogenesis of Alzheimer's disease.

Authors:  B Paul Morgan
Journal:  Semin Immunopathol       Date:  2017-11-13       Impact factor: 9.623

View more
  121 in total

Review 1.  NAD+ metabolism and its roles in cellular processes during ageing.

Authors:  Anthony J Covarrubias; Rosalba Perrone; Alessia Grozio; Eric Verdin
Journal:  Nat Rev Mol Cell Biol       Date:  2020-12-22       Impact factor: 94.444

Review 2.  Krebs cycle: activators, inhibitors and their roles in the modulation of carcinogenesis.

Authors:  Amin Gasmi; Massimiliano Peana; Maria Arshad; Monica Butnariu; Alain Menzel; Geir Bjørklund
Journal:  Arch Toxicol       Date:  2021-03-02       Impact factor: 5.153

3.  Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of modulating NAD+ levels in hSOD1-linked ALS mouse models.

Authors:  Benjamin A Harlan; Kelby M Killoy; Mariana Pehar; Liping Liu; Johan Auwerx; Marcelo R Vargas
Journal:  Exp Neurol       Date:  2020-01-31       Impact factor: 5.330

4.  NAD metabolism in aging and cancer.

Authors:  John Wr Kincaid; Nathan A Berger
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-05

Review 5.  The wrinkling of time: Aging, inflammation, oxidative stress, and the circadian clock in neurodegeneration.

Authors:  Brian V Lananna; Erik S Musiek
Journal:  Neurobiol Dis       Date:  2020-03-13       Impact factor: 5.996

Review 6.  NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.

Authors:  Na Xie; Lu Zhang; Wei Gao; Canhua Huang; Peter Ernst Huber; Xiaobo Zhou; Changlong Li; Guobo Shen; Bingwen Zou
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

7.  The NAD+-mitophagy axis in healthy longevity and in artificial intelligence-based clinical applications.

Authors:  Yahyah Aman; Johannes Frank; Sofie Hindkjær Lautrup; Adrian Matysek; Zhangming Niu; Guang Yang; Liu Shi; Linda H Bergersen; Jon Storm-Mathisen; Lene J Rasmussen; Vilhelm A Bohr; Hilde Nilsen; Evandro F Fang
Journal:  Mech Ageing Dev       Date:  2019-12-05       Impact factor: 5.432

8.  Nicotinamide Mononucleotide Prevents Cisplatin-Induced Cognitive Impairments.

Authors:  Ki Hyun Yoo; Jason J Tang; Mohammad Abdur Rashid; Chang Hoon Cho; Ana Corujo-Ramirez; Jonghoon Choi; Mun Gyeong Bae; Danielle Brogren; John R Hawse; Xiaonan Hou; S John Weroha; Alfredo Oliveros; Lindsey A Kirkeby; Joseph A Baur; Mi-Hyeon Jang
Journal:  Cancer Res       Date:  2021-03-26       Impact factor: 12.701

9.  Hypoxia ameliorates brain hyperoxia and NAD+ deficiency in a murine model of Leigh syndrome.

Authors:  Robert M H Grange; Rohit Sharma; Hardik Shah; Bryn Reinstadler; Olga Goldberger; Marissa K Cooper; Akito Nakagawa; Yusuke Miyazaki; Allyson G Hindle; Annabelle J Batten; Gregory R Wojtkiewicz; Grigorij Schleifer; Aranya Bagchi; Eizo Marutani; Rajeev Malhotra; Donald B Bloch; Fumito Ichinose; Vamsi K Mootha; Warren M Zapol
Journal:  Mol Genet Metab       Date:  2021-03-11       Impact factor: 4.797

Review 10.  Molecular regulation of neuroinflammation in glaucoma: Current knowledge and the ongoing search for new treatment targets.

Authors:  Gülgün Tezel
Journal:  Prog Retin Eye Res       Date:  2021-08-01       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.